Antigua and Barbuda vs Korea: Immunization, measles
Antigua and Barbuda
97.0%
in 2024
Korea
97.0%
in 2024
Antigua and Barbuda rank
31st
Korea rank
31st
Immunization, measles over time
- Antigua and Barbuda
- Korea
How they compare
Antigua and Barbuda currently reports 97.0% against 97.0% in Korea, a difference of 0.0%.
The two have swapped places 15 times across 42 shared years of data; in 1983 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 31st and Korea ranks 31st of 193 countries.
Across the 5 decades both report, Antigua and Barbuda averaged higher in 3 and Korea in 2.
Head to head by decade
| Decade | Antigua and Barbuda | Korea | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 78.4% | 74.1% | 4.3% | Antigua and Barbuda |
| 1990s | 94.8% | 90.5% | 4.3% | Antigua and Barbuda |
| 2000s | 98.2% | 95.8% | 2.4% | Antigua and Barbuda |
| 2010s | 95.5% | 98.3% | 2.8% | Korea |
| 2020s | 92.8% | 97.4% | 4.6% | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles, Antigua and Barbuda or Korea?
- Antigua and Barbuda, at 97.0% against 97.0% in Korea as of 2024.
- What is the difference in immunization, measles between Antigua and Barbuda and Korea?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Korea?
- 42 years are reported by both, from 1983 to 2024.
- How do Antigua and Barbuda and Korea rank globally for immunization, measles?
- Antigua and Barbuda ranks 31st and Korea ranks 31st of 193 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.